Amplification of telomerase reverse transcriptase gene in human mammary epithelial cells with limiting telomerase RNA expression levels

被引:16
作者
Cao, Ying [1 ,2 ]
Huschtscha, Lily I. [1 ,2 ]
Nouwens, Amanda S. [1 ,2 ]
Pickett, Hilda A. [1 ,2 ]
Neumann, Axel A. [1 ,2 ]
Chang, Andy C-M. [1 ,2 ]
Toouli, Christian D. [1 ,2 ]
Bryan, Tracy M. [1 ,2 ]
Reddel, Roger R. [1 ,2 ]
机构
[1] Childrens Med Res Inst, Westmead, NSW, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
基金
英国惠康基金;
关键词
D O I
10.1158/0008-5472.CAN-07-6377
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activation of telomerase is a crucial step during cellular immortalization, and in some tumors this results from amplification of the human telomerase reverse transcriptase (hTERT) gene. Immortalization of normal human cells has been achieved by transduction with hTERT cDNA under the control of a strong heterologous enhancer/promoter, but this is sometimes an inefficient process, with periods of poor growth or even crisis occurring before immortalization. Here, we showed that normal human mammary epithelial cells expressing exogenous hTERT amplified the transgene extensively and expressed high levels of hTERT mRNA and protein. Paradoxically, the cells had low levels of telomerase activity and very short telomeres, indicating that telomerase activity did not correlate with hTERT expression. These cells contained only similar to 20 human telomerase RNA (hTR) molecules/cell (compared with similar to 120 hTR molecules per 293 cell). Expression of exogenous hTR caused increased telomerase activity and telomere lengthening. These data indicate that some hTERT-transduced normal cells may express high levels of the transgene but fail to up-regulate endogenous hTR expression sufficiently to enable expression of robust levels of telomerase activity.
引用
收藏
页码:3115 / 3123
页数:9
相关论文
共 51 条
[1]   Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas [J].
Andersson, S. ;
Wallin, K-L ;
Hellstroem, A-C ;
Morrison, L. E. ;
Hjerpe, A. ;
Auer, G. ;
Ried, T. ;
Larsson, C. ;
Heselmeyer-Haddad, K. .
BRITISH JOURNAL OF CANCER, 2006, 95 (03) :331-338
[2]  
Avilion AA, 1996, CANCER RES, V56, P645
[3]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[4]   The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit [J].
Bryan, TM ;
Marusic, L ;
Bacchetti, S ;
Namba, M ;
Reddel, RR .
HUMAN MOLECULAR GENETICS, 1997, 6 (06) :921-926
[5]   TELOMERE ELONGATION IN IMMORTAL HUMAN-CELLS WITHOUT DETECTABLE TELOMERASE ACTIVITY [J].
BRYAN, TM ;
ENGLEZOU, A ;
GUPTA, J ;
BACCHETTI, S ;
REDDEL, RR .
EMBO JOURNAL, 1995, 14 (17) :4240-4248
[6]   TERT regulates cell survival independent of telomerase enzymatic activity [J].
Cao, Y ;
Li, H ;
Deb, S ;
Liu, JP .
ONCOGENE, 2002, 21 (20) :3130-3138
[7]   Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere length maintenance in vivo [J].
Chiang, YJ ;
Hemann, MT ;
Hathcock, KS ;
Tessarollo, L ;
Feigenbaum, L ;
Hahn, WC ;
Hodes, RJ .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (16) :7024-7031
[8]  
COHEN SB, 2008, IN PRESS NAT METHODS
[9]   Protein composition of catalytically active human telomerase from immortal cells [J].
Cohen, Scott B. ;
Graham, Mark E. ;
Lovrecz, George O. ;
Bache, Nicolai ;
Robinson, Phillip J. ;
Reddel, Roger R. .
SCIENCE, 2007, 315 (5820) :1850-1853
[10]   The hTERTα splice variant is a dominant negative inhibitor of telomerase activity [J].
Colgin, LM ;
Wilkinson, C ;
Englezou, A ;
Kilian, A ;
Robinson, MO ;
Reddel, RR .
NEOPLASIA, 2000, 2 (05) :426-432